World Health Organization: The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed December 9, 2020.
Saeedi P, Petersohn I, Salpea P, et al: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157: 107843, 2019.
International Diabetes Federation: IDF Diabetes Atlas, 10th Ed, 2021 Available at: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf. Accessed August 1, 2021.
Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. JAMA 293: 217, 2005.
Alhowaish A: Economic costs of diabetes in Saudi Arabia. J Family Community Med 20: 1, 2013.
Alshammary S, Othman SA, Alshammari E, et al: Economic impact of diabetic foot ulcers on healthcare in Saudi Arabia: a retrospective study. Ann Saudi Med 40: 425, 2020.
Zhao D, Cho J, Kim MH, et al: Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology 122: 72, 2015.
Mathew TK, Zubair M, Tadi P: Blood Glucose Monitoring, StatPearls Publishing, Treasure Island, FL, 2023.
Flegel K: Controlling the complications of diabetes: it’s about the sugar. CMAJ 181: 357, 2009.
Saudi National Diabetes Center: Saudi Diabetes Clinical Practice Guidelines (SDCPG). Available at: https://shc.gov.sa/arabic/documents/sdcp%20guidelines.pdf. Accessed August 1, 2021.
Dogan M, Onar LC, Aydin B, et al: Is high level of hemoglobin A1C an indicator for extended period of antibiotherapy in diabetic foot ulcers? North Clin Istanb 6: 21, 2019.
Abuhay HW, Yenit MK, Wolde HF: Incidence and predictor of diabetic foot ulcer and its association with change in fasting blood sugar among diabetes mellitus patients at referral hospitals in Northwest Ethiopia, 2021. PLoS One 17: e0274754, 2022.
Salawu AI, Ajani GO, Soje MO, et al: Diabetes mellitus foot ulcer and associated factors among type 2 diabetes patients in a tertiary institution in Southwest Nigeria. Ann Afr Med 21: 339, 2022.
Premkumar R, Rajan P, Rima J, et al: Footwear in the causation and prevention of foot ulcers in diabetes mellitus. Natl Med J India 30: 255, 2017.
Trivedi H, Gray LJ, Seidu S, et al: Self-knowledge of HbA1c in people with type 2 diabetes mellitus and its association with glycaemic control. Prim Care Diabetes 11: 414, 2017.
Almutairi JS, Almigbal TH, Alruhaim HY, et al: Self-awareness of HbA1c and its association with glycemic control among patients with type 2 diabetes: a multicenter study. Saudi Med J 43: 291, 2022.
Ali M, Khan MNA, Patel MJ: Pattern and knowledge of HbA1c testing among diabetic patients at The Indus Hospital (TIH), Karachi. Liaquat Natl J Prim Care 5: 207, 2022.
Heisler M, Piette JD, Spencer M, et al: The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Available at: http://diabetesjournals.org/care/article-pdf/28/4/816/566330/zdc00405000816.pdf. Accessed April 1, 2005.
Vieira MB, Neves JS, Leitão L, et al: Impaired fasting glucose and chronic kidney disease, albuminuria, or worsening kidney function: a secondary analysis of SPRINT. J Clin Endocrinol Metab 104: 4024, 2019.
Sorkin JD, Muller DC, Fleg JL, et al: The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28: 2626, 2005.
Unwin N, Shaw J, Zimmet P, et al: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19: 708, 2002.
Wong TY, Liew G, Tapp RJ, et al: Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 371: 736, 2008.
Shaye K, Amir T, Shlomo S, et al: Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J 164: 111, 2012.
Almaramhy H, Mahabbat NA, Fallatah KY, et al: The correlation of fasting blood glucose levels with the severity of diabetic foot ulcers and the outcome of treatment strategies. Biomed Res 29: 1961, 2018.
Nang EEK, Khoo CM, Tai ES, et al: Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease? The Singapore Prospective Study Program. Am J Epidemiol 169: 1454, 2009.
Waaijman R, Keukenkamp R, de Haart M, et al: Adherence to wearing prescription custom-made footwear in patients with diabetes at high risk for plantar foot ulceration. Diabetes Care 36: 1613, 2013.
Zwaferink JBJ, Custers W, Paardekooper I, et al: Optimizing footwear for the diabetic foot: data-driven custom-made footwear concepts and their effect on pressure relief to prevent diabetic foot ulceration. PLoS One 15: e0224010, 2020.
Bus SA, Waaijman R, Arts M, et al: Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care 36: 4109, 2013.
Background: This cross-sectional study aimed to identify patients’ awareness of predictors of diabetic foot complications (DFCs) based on 1) knowledge of hemoglobin A1c (HbA1c), 2) performance of fasting blood glucose (FBG) at home, and 3) type of footwear used and relationship with DFCs.
Methods: A total of 4,652 diabetic patients were seen between 2006 and 2021 at Dr. Khalid Edrees Specialized Medical Center. A questionnaire was completed by trained nurses at the patients’ initial visit, collecting patients’ knowledge of the HbA1c test, monitoring of FBG at home, and type of footwear used at the time of the visit. History of foot ulcers, current foot ulceration (CU), and history of lower limb amputation (LLA) were obtained.
Results: The majority of our cohort were male (60%), and the mean age was 60 years (SD, 17.5 years). Ninety-six percent had type 2 diabetes, and 39% were diagnosed with diabetes for at least 11 years. More than half did not know what HbA1c was, 32% were not doing home FBG, and 62% were using inappropriate footwear. Fifty-two percent had a CU, 35% had a history of foot ulcers, and 13% had an LLA. We found a significant association between CU and knowledge of HbA1c and type of footwear (P < .001). Similarly, LLA was significantly associated with all of the aforementioned variables (P < .001). A history of foot ulcers was significantly associated with knowledge of HbA1c and type of footwear (P = .001) but not with home FBG.
Conclusions: A high proportion of patients in our cohort had never heard of HbA1c and were using traditional footwear. This highlights the importance of patient education regarding the basics of diabetes and the use of appropriate footwear in preventing DFCs.